Viridien
CGPVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,211 | $1,076 | $882 | $899 |
| % Growth | 12.6% | 22% | -1.9% | – |
| Cost of Goods Sold | $871 | $817 | $623 | $722 |
| Gross Profit | $340 | $258 | $259 | $177 |
| % Margin | 28.1% | 24% | 29.3% | 19.7% |
| R&D Expenses | $18 | $26 | $34 | $30 |
| G&A Expenses | $83 | $76 | $68 | $63 |
| SG&A Expenses | $120 | $112 | $98 | $93 |
| Sales & Mktg Exp. | $37 | $36 | $30 | $30 |
| Other Operating Expenses | $59 | $1 | $0 | $1 |
| Operating Expenses | $197 | $139 | $127 | $108 |
| Operating Income | $144 | $119 | $132 | $69 |
| % Margin | 11.8% | 11.1% | 15% | 7.7% |
| Other Income/Exp. Net | $0 | -$101 | -$68 | -$163 |
| Pre-Tax Income | $50 | $18 | $64 | -$157 |
| Tax Expense | $13 | $14 | $16 | -$4 |
| Net Income | $50 | $13 | $43 | -$154 |
| % Margin | 4.1% | 1.2% | 4.9% | -17.2% |
| EPS | 6.66 | 1.81 | 5.76 | -21.69 |
| % Growth | 268% | -68.6% | 126.6% | – |
| EPS Diluted | 6.63 | 1.8 | 5.74 | -21.69 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $8 | $2 | $1 |
| Interest Expense | $103 | $105 | $102 | $117 |
| Depreciation & Amortization | $108 | $76 | $251 | $316 |
| EBITDA | $268 | $199 | $435 | $386 |
| % Margin | 22.1% | 18.5% | 49.3% | 42.9% |